Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical and Experimental Nephrology
Metadata
Title
Hypocomplementemia and membranoproliferative glomeruloneophritis in children
Authors
Kikuo Iitaka
Shinya Nakamura
Shunsuke Moriya
Hiroe Koshino
Naomi Iwanami
Tadasu Sakai
Osamu Motoyama
Publication date
01-03-2005
Publisher
Springer-Verlag
Published in
Clinical and Experimental Nephrology / Issue 1/2005
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-004-0330-y

Other articles of this Issue 1/2005

Clinical and Experimental Nephrology 1/2005 Go to the issue

ORIGINAL ARTICLE

Risk factors for bleeding complications in percutaneous renal biopsy

ORIGINAL ARTICLE

Urinary excretion of liver fatty acid-binding protein in health-check participants

REVIEW ARTICLE

An analysis of current quantitative approaches to the treatment of severe symptomatic SIADH with intravenous saline therapy

ORIGINAL ARTICLE

Vitamin C may be beneficial in the prevention of paracetamol-induced renal damage

ORIGINAL ARTICLE

Relationship between dyslipidemia and the risk of developing end-stage renal disease in a screened cohort

CASE REPORT

A case of necrotizing glomerulonephritis presenting with nephrotic syndrome associated with pulmonary cryptococcosis

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits